Das Klinikum

Dr. Yogesh Singh

Dr. Yogesh Singh

Group Leader/Principal Investigator

Medical Genetics and Applied Genomics
NGS Competence Centre Tübingen (NCCT)
Research Institute of Women's Hospital
Calwerstraße 7, 72076
Tübingen, Germany


Telefonnummer: 07071 29-78264

E-Mail-Adresse: yogesh.singh@med.uni-tuebingen.de

  • Cellular and Genomic Immunology
  • Microbiome and Inflammation
  • COVID19: Understanding the function of antigen-specific (TCR/BCR) in COVID-19 using multi-OMICS tools
  • Track.a.TCR: COVID-19 vaccination and Long-term immune response
  • Neurodegeneration & ageing: Innate and adaptive immune response after the gut microbiome manipulation in Parkinson's disease (PD)
  • Maintained imbalance of triglycerides, apolipoproteins, energy metabolites and cytokines in long-term COVID-19 syndrome patients.Berezhnoy G, Bissinger R, Liu A, Cannet C, Schäfer H, Kienzle K, Bitzer M, Häberle H, Göpel S, Trautwein C, Singh Y. Front Immunol. 2023 May 9;14:1144224. doi: 10.3389/fimmu.2023.1144224
  • Yogesh Singh, Christoph Trautwein, Joan Romani, Madhuri S Salker, Peter H Neckel, Isabel Fraccaroli, Mahkameh Abeditashi, Nils Woerner, Jakob Admard, Achal Dhariwal, Morten S Dueholm, Karl-Herbert Schäfer, Florian Lang, Daniel Otzen, Hilal A Lashuel, Olaf Riess, Nicolas Casadei. 2023 Molecular Neurodegeneration.doi: https://doi.org/10.1101/2020.12.23.424226
  • Zhang S, al-Maghout T, Cao H, Pelzl L, Salker M, Veldhoen M, Cheng A, Lang F, Singh Y. Gut bacterial metabolit Urolithin A (UA) mitigates Ca2+ entry in T cells by regulating miRNA-10a-5p. Front. Immunology, 2019.
  • Publikationen